Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
[PMID: 25506801] PubMed record related to this compound for laboratory literature review
One should not use AOD-9604 if they: Are pregnant or breastfeeding Are a minor Have a current or recent history of cancer (particularly hormone-sensitive cancers) Have uncontrolled diabetes or significant insulin resistance Have active thyroid disease that is not well-managed Are taking medications that may interact with peptide therapy (discuss with your provider) Have a known hypersensitivity to peptide compounds Comprehensive labs including metabolic panel, fasting glucose, HbA1c, thyroid panel, lipid panel, and hormone levels should be run before starting any peptide therapy and monitored regularly throughout
Paris 91 (3-5), 173178
At the standard escalation of 2.5 mg for 4 weeks then 5 mg, you would use 10 mg in the first month (4 doses at 2.5 mg) and then continue at 5 mg per week
A 5mg dose at 5mg/mL concentration is 1mL
Liebowitz says
